Twist bioscience corp (TWST)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17
Cash flows from operating activities
Net loss

-31,768

-55,638

-31,181

-27,916

-25,933

-22,639

-19,802

-17,624

-16,873

-16,937

Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization

1,559

1,505

1,489

1,587

1,563

1,472

1,329

1,697

1,415

1,286

Loss on disposal of property and equipment

-

-

13

-194

0

-8

-

-

-

-

Non-cash lease expense

-463

236

-

-

-

-

-

-

-

-

Stock-based compensation

4,197

3,697

3,363

3,032

2,911

1,864

1,086

603

736

536

Discount accretion on investment securities

82

150

-

-

-

-

-

-

-

-

Non-cash interest expense

41

46

51

57

61

64

104

63

70

17

Change in fair value of redeemable convertible preferred stock warrant liability

-

-

-

-

-

-

-79

20

48

-2

Amortization of debt discount

49

56

63

67

74

78

78

77

60

93

Changes in assets and liabilities:
Accounts receivable, net

1,777

950

577

3,529

1,020

1,559

1,130

273

993

677

Inventories

3,347

86

1,834

1,047

-1,112

-467

1,776

1,139

841

446

Prepaid expenses and other current assets

-964

2,917

-868

-609

365

366

964

304

582

-90

Other non-current assets

258

-62

1,622

251

-201

392

-640

1,193

148

111

Accounts payable

-2,519

-556

3,374

1,921

-1,302

-715

2,220

232

353

954

Accrued expenses

-1,758

-1,279

2,249

1,303

619

39

-632

448

732

-662

Accrued compensation

-219

-1,629

585

2,440

2,175

-140

2,022

343

-361

-72

Accrued litigation settlement

-

22,500

-

-

-

-

-

-

-

-

Other liabilities

-790

189

108

-102

-388

135

208

89

-162

-85

Net cash used in operating activities

-58,671

-34,914

-23,358

-22,082

-20,813

-21,684

-16,696

-16,942

-16,510

-16,016

Cash flows from investing activities
Purchases of property and equipment

2,737

2,058

3,893

5,172

3,770

1,922

1,047

629

501

1,511

Purchases of investments

0

6,537

40,310

50,639

22,790

63,835

149

0

0

3,374

Proceeds from maturity of investments

31,500

21,000

-

-

-

-

1,600

5,200

14,600

13,100

Net cash provided by (used in) investing activities

28,763

12,405

-1,187

-22,706

-15,160

-65,757

404

4,580

14,107

8,215

Cash flows from financing activities
Proceeds from exercise of stock options

1,387

1,674

1,061

864

25

220

40

9

140

142

Proceeds from public offering, net of underwriting discounts and commissions and offering expenses

186,352

2,024

0

84,255

-826

72,779

-

-

-

-

Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs

-

-

-

-

-

-

6,977

24,911

55,972

2,990

Payments of deferred offering costs

-

-

-

-

-

-

434

90

1,365

470

Repayments of long-term debt

834

833

-

-

-

-

-

-

-

-

Repurchases of common stock for income tax withholding

390

808

-

-

-

-

-

-

-

-

Net cash provided by financing activities

188,037

2,057

2,928

84,285

-1,634

72,999

6,583

24,830

54,747

2,662

Effect of exchange rates on cash, cash equivalents and restricted cash

-27

9

-

-

-

-

-

-

-

-

Net increase (decrease) in cash, cash equivalents and restricted cash

158,102

-20,443

-21,587

39,497

-37,607

-14,442

-9,709

12,468

52,344

-5,139

Supplemental disclosure of cash flow information
Interest paid

125

146

174

192

206

207

164

197

187

203

Income taxes paid, net of refunds

76

44

70

60

108

53

159

8

7

5

Non-cash investing and financing activities
Property and equipment additions included in accrued expenses and accounts payable

708

66

-1,103

1,087

-931

1,117

-

-

-202

226

Operating lease right-of-use assets obtained in exchange for operating lease liabilities

0

2,833

-

-

-

-

-

-

-

-

Offering expenses included in accounts payable and accrued expenses

-

-

-

-

-806

826

792

476

-47

87

Conversion of redeemable convertible preferred stock warrant liability to equity

-

-

0

0

0

631

-

-

-

-

Conversion of redeemable convertible preferred stock to common stock

-

-

0

0

0

290,462

-

-

-

-